Ntlotlang Mokgautsi

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 24

Top Topics

Molecular Docking

Cardiopulmonary Resuscitation

Transcription Factor

Top Venues

International journal of molecular sciences

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Jing-Wen Shih, Alexander Tsang-Hsien Wu, Ntlotlang Mokgautsi, Po-Li Wei, Yan-Jiun Huang
Preclinical Repurposing of Sitagliptin as a Drug Candidate for Colorectal Cancer by Targeting CD24 / CTNNB1 / SOX4 -Centered Signaling Hub. International journal of molecular sciences 25 (1) (2024)
Jing-Wen Shih, Alexander Tsang-Hsien Wu, Ntlotlang Mokgautsi, Po-Li Wei, Yan-Jiun Huang
Preclinical Repurposing of Sitagliptin as a Drug Candidate for Colorectal Cancer by Targeting CD24 / CTNNB1 / SOX4 -Centered Signaling Hub. International journal of molecular sciences 25 (1) (2024)
Jing-Wen Shih, Alexander Tsang-Hsien Wu, Ntlotlang Mokgautsi, Po-Li Wei, Yan-Jiun Huang
Preclinical Repurposing of Sitagliptin as a Drug Candidate for Colorectal Cancer by Targeting CD24 / CTNNB1 / SOX4 -Centered Signaling Hub. International journal of molecular sciences 25 (1) (2024)
Ntlotlang Mokgautsi, Yu-Cheng Kuo, Yan-Jiun Huang, Chien-Hsin Chen, Debabrata Mukhopadhyay, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures. Cells 12 (2) (2023)
Ntlotlang Mokgautsi, Yu-Cheng Kuo, Chien-Hsin Chen, Yan-Jiun Huang, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer. Cells 12 (2) (2023)
Harold A Chinyama, Li Wei, Ntlotlang Mokgautsi, Bashir Lawal, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
Identification of CDK1, PBK, and CHEK1 as an Oncogenic Signature in Glioblastoma: A Bioinformatics Approach to Repurpose Dapagliflozin as a Therapeutic Agent. International journal of molecular sciences 24 (22) (2023)
Lung-Ching Chen, Ntlotlang Mokgautsi, Yu-Cheng Kuo, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
In Silico Evaluation of HN-N07 Small Molecule as an Inhibitor of Angiogenesis and Lymphangiogenesis Oncogenic Signatures in Non-Small Cell Lung Cancer. Biomedicines 11 (7) (2023)
Ntlotlang Mokgautsi, Yu-Cheng Kuo, Yan-Jiun Huang, Chien-Hsin Chen, Debabrata Mukhopadhyay, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures. Cells 12 (2) (2023)
Yi-Fong Chen, Bashir Lawal, Li-Jiau Huang, Sheng-Chu Kuo, Maryam Rachmawati Sumitra, Ntlotlang Mokgautsi, Hung-Yun Lin, Hsu-Shan Huang
In Vitro and In Silico Biological Studies of 4-Phenyl-2-quinolone (4-PQ) Derivatives as Anticancer Agents. Molecules (Basel, Switzerland) 28 (2) (2023)
Ntlotlang Mokgautsi, Yu-Cheng Kuo, Yan-Jiun Huang, Chien-Hsin Chen, Debabrata Mukhopadhyay, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures. Cells 12 (2) (2023)
Ntlotlang Mokgautsi, Yu-Cheng Kuo, Chien-Hsin Chen, Yan-Jiun Huang, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer. Cells 12 (2) (2023)
Ntlotlang Mokgautsi, Yu-Cheng Kuo, Chien-Hsin Chen, Yan-Jiun Huang, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer. Cells 12 (2) (2023)
Ntlotlang Mokgautsi, Yu-Cheng Kuo, Yan-Jiun Huang, Chien-Hsin Chen, Debabrata Mukhopadhyay, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures. Cells 12 (2) (2023)
Ntlotlang Mokgautsi, Yu-Cheng Kuo, Chien-Hsin Chen, Yan-Jiun Huang, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer. Cells 12 (2) (2023)
Yi-Fong Chen, Bashir Lawal, Li-Jiau Huang, Sheng-Chu Kuo, Maryam Rachmawati Sumitra, Ntlotlang Mokgautsi, Hung-Yun Lin, Hsu-Shan Huang
In Vitro and In Silico Biological Studies of 4-Phenyl-2-quinolone (4-PQ) Derivatives as Anticancer Agents. Molecules (Basel, Switzerland) 28 (2) (2023)
Yi-Fong Chen, Bashir Lawal, Li-Jiau Huang, Sheng-Chu Kuo, Maryam Rachmawati Sumitra, Ntlotlang Mokgautsi, Hung-Yun Lin, Hsu-Shan Huang
In Vitro and In Silico Biological Studies of 4-Phenyl-2-quinolone (4-PQ) Derivatives as Anticancer Agents. Molecules (Basel, Switzerland) 28 (2) (2023)
Ntlotlang Mokgautsi, Yu-Cheng Kuo, Sung-Ling Tang, Feng-Cheng Liu, Shiang-Jiun Chen, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
Anticancer Activities of 9-chloro-6-(piperazin-1-yl)-11H-indeno[1,2-c] quinolin-11-one (SJ10) in Glioblastoma Multiforme (GBM) Chemoradioresistant Cell Cycle-Related Oncogenic Signatures. Cancers 14 (1) (2022)
Wai-Hung Leung, Jing-Wen Shih, Jian-Syun Chen, Ntlotlang Mokgautsi, Po-Li Wei, Yan-Jiun Huang
Preclinical Identification of Sulfasalazine's Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling. Biomedicines 10 (2) (2022)
Ntlotlang Mokgautsi, Yu-Chi Wang, Bashir Lawal, Harshita Nivrutti Khedkar, Maryam Rachmawati Sumitra, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
Network Pharmacological Analysis through a Bioinformatics Approach of Novel NSC765600 and NSC765691 Compounds as Potential Inhibitors of CCND1/CDK4/PLK1/CD44 in Cancer Types. Cancers 13 (11) (2021)
Harshita Nivrutti Khedkar, Yu-Chi Wang, Vijesh Kumar Yadav, Prateeti Srivastava, Bashir Lawal, Ntlotlang Mokgautsi, Maryam Rachmawati Sumitra, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1. International journal of molecular sciences 22 (11) (2021)
Ntlotlang Mokgautsi, Ya-Ting Wen, Bashir Lawal, Harshita Khedkar, Maryam Rachmawati Sumitra, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential GSK3β/β-Catenin/STAT3/CD44 Suppressor with Anti-Glioblastoma Properties. International journal of molecular sciences 22 (5) (2021)
Alexander Tsang-Hsien Wu, Hsu-Shan Huang, Ya-Ting Wen, Bashir Lawal, Ntlotlang Mokgautsi, Thanh-Tuan Huynh, Michael Hsiao, Li Wei
A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling. Cells 10 (9) (2021)
Bashir Lawal, Yen-Lin Liu, Ntlotlang Mokgautsi, Harshita Khedkar, Maryam Rachmawati Sumitra, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines. Biomedicines 9 (1) (2021)
Tse-Hung Huang, Ntlotlang Mokgautsi, Yan-Jiun Huang, Alexander Tsang-Hsien Wu, Hsu-Shan Huang
Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects. Cells 10 (8) (2021)